ABOUT US

Novilytic is a biochemistry analytics company that protects and secures lifesaving drugs and medical devices.   

The company is backed by: 

• >25 patents 

• $2B Analytical Instrument Co. 

• 2 Pharmaceutical Consortiums 

• 2 Med & Analytical Universities 

Our potency is extended by our people which includes 5 Ph.D. Chemists and Engineers who have helped us secure significant patents and other IP.  Our business plan will increase those forces to ensure we meet customer, market, and regulatory demands. ​

The Novilytic Product Lines complete the balance of Novilytic’s strength.  They include: 

• The Proteometer™ - Disruptive Instrument for pharmaceutical processing 

• NoviChrom™ Analytical Columns 

• Consumables for the Proteometer 

• NoviQuest™ & NoviMASC Reagents 

• Consumables for the Proteometer 

• NoviPlex™ Blood Collection Devices - Most advanced global collection device 

​

Novilytic is pursuing Seed Funding to bring the Proteometer to market.  With significant strategic advantages, patents, and other IP, Novilytic is expected to experience significant growth over the next 3-4 years.